Company Filing History:
Years Active: 2011-2016
Title: The Innovations of Stephen Watt
Introduction
Stephen Watt is a notable inventor based in Riccarton, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on genistein. With a total of three patents to his name, Watt's inventions focus on the therapeutic applications of crystalline forms of genistein.
Latest Patents
Watt's latest patents revolve around new crystalline forms of genistein. These include crystalline genistein sodium salt dihydrate, crystalline genistein potassium salt dihydrate, crystalline genistein calcium salt, crystalline genistein magnesium salt, crystalline genistein L-lysine salt, crystalline genistein N-methylglucamine salt, crystalline genistein N-ethylglucamine salt, crystalline genistein diethylamine salt, and crystalline genistein monohydrate. The patents also describe therapeutic compositions that contain at least one of these crystalline forms of genistein or a genistein salt, along with a pharmaceutically acceptable carrier. Furthermore, the disclosures relate to methods of treating cancer by administering a therapeutically effective amount of these compositions to patients in need.
Career Highlights
Throughout his career, Stephen Watt has worked with various companies, including Axcentua Pharmaceuticals AB. His work has significantly impacted the pharmaceutical industry, particularly in the development of innovative therapeutic solutions.
Collaborations
Watt has collaborated with notable professionals in his field, including Anders Berkenstam and Stefan Rehnmark. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Stephen Watt's contributions to the field of pharmaceuticals through his patents on genistein highlight his role as an influential inventor. His work continues to pave the way for new therapeutic approaches in cancer treatment.